tetrahydrocortisol has been researched along with medroxyprogesterone acetate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, J; Hori, M; Ichigo, S; Tamaya, T | 1 |
| Fujimoto, J; Hirose, R; Ichigo, S; Sakaguchi, H; Tamaya, T | 1 |
2 other study(ies) available for tetrahydrocortisol and medroxyprogesterone acetate
| Article | Year |
|---|---|
Sex steroids regulate the expression of plasminogen activator inhibitor-1 and its mRNA in fibroblasts derived from uterine endometrium.
Topics: 17-alpha-Hydroxyprogesterone; Dose-Response Relationship, Drug; Endometrium; Estradiol; Female; Fibroblasts; Gonadal Steroid Hormones; Humans; Hydrocortisone; Medroxyprogesterone Acetate; Plasminogen Activator Inhibitor 1; Progesterone; RNA, Messenger; Tetrahydrocortisol | 1996 |
Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cells.
Topics: 17-alpha-Hydroxyprogesterone; Blotting, Southern; Blotting, Western; Dose-Response Relationship, Drug; Endometrial Neoplasms; Endothelial Growth Factors; Estradiol; Female; Humans; Hydrocortisone; Immunoenzyme Techniques; Lymphokines; Medroxyprogesterone Acetate; Progesterone; Progestins; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrahydrocortisol; Time Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |